Eduardo De Pablo-Fernández
Neurologist at the Center for Preventive Neurology at Queen Mary University in London and at the UCL Queen Square Brain Bank. Host of this MDS podcast episode.
Top 3 podcasts with Eduardo De Pablo-Fernández
Ranked by the Snipd community
Aug 21, 2024 • 2min
Interpreting DAT Imaging Results in the Clinical Context - Part 2
Dr. Jeff Ratliff, a clinical expert in dopaminergic imaging, joins Dr. Eduardo De Pablo-Fernández, a specialist in clinical interpretations, to discuss critical insights into the limitations of DAT imaging in diagnosing Parkinsonism. They caution against over-reliance on imaging, highlighting potential pitfalls in cases like corticobasal syndrome and progressive supranuclear palsy. The conversation emphasizes the need for careful consideration in differential diagnosis to avoid misleading interpretations.
Aug 16, 2024 • 2min
Interpreting DAT Imaging Results in the Clinical Context
Dr. Jeff Ratliff, a specialist in dopaminergic imaging techniques, teams up with Dr. Eduardo De Pablo-Fernández, an expert in Parkinsonian disorder diagnostics. They delve into the vital role of dopamine transporter imaging in diagnosing Parkinsonism, highlighting its impressive negative predictive value. The conversation also touches on the limitations of this imaging method, providing a balanced view of its efficacy in clinical settings. Listeners gain key insights into how imaging impacts the diagnosis and management of these complex disorders.
Aug 15, 2024 • 18min
Interpreting DAT Imaging Results in the Clinical Context
Dr. Jeff Ratliff, a specialist in DAT imaging, joins Dr. Eduardo De Pablo-Fernández, an expert on Parkinsonian disorders, to discuss the critical role of dopamine transporter imaging in diagnosis. They explore how DAT imaging can effectively differentiate between Parkinson's disease and multiple system atrophy, while also addressing its limitations in tau-related conditions. Key insights include the influence of alpha-synuclein on neurodegenerative disorders and the challenges of interpreting imaging results, particularly for progressive supranuclear palsy.
